Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 17, No 3 (2021) Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome Abstract  similar documents
A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova
 
Vol 17, No 3 (2021) An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus Abstract  similar documents
V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova
 
Vol 13, No 5 (2017) ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM – CASE REPORT Abstract  similar documents
S. D. Klimovskiy, G. G. Gazaryan, M. D. Krichman, P. B. Pisetskiy, A. G. Koledinskiy, T. Sh. Mirilashvili
 
Vol 13, No 6 (2017) ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE Abstract  similar documents
E. A. Kolomiets, I. A. Kurmukov, Sh. R. Kashiya, N. S. Besova, S. V. Limareva, A. P. Sandomirskaya
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... and IgG levels to MRI-MRIV (p=0.02) revealed. Increase in titre of antibodies to β1-adrenoceptors ..."
 
Vol 4, No 4 (2008) EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE Abstract  similar documents
I. Graham, D. Ata, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backe, Sh. Ebrahim, B. Gjelsvik, Ch. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reime, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
"... ,9 days (p<0,05), respectively, as well as the more prominent basal pulse deficit, 24,6±15,0 vs 13,56±5 ..."
 
Vol 2, No 1 (2006) THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY Abstract  similar documents
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov
 
Vol 16, No 2 (2020) Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function Abstract  similar documents
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko
 
Vol 16, No 3 (2020) The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention Abstract  PDF (Eng)  similar documents
Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk
"... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p<0.001), 3 months after PCI ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... , triglyceride (p<0.001) and significant increase in high-density lipoprotein cholesterol (p<0.001) when compared ..."
 
Vol 12, No 5 (2016) Lung Function Parameters in Patients with Dilated Cardiomyopathy Complicated by Pulmonary Hypertension Abstract  similar documents
T. A. Abdullaev, Ya. R. Ahmatov, B. U. Mardanov, R. Sh. Bekbulatova
"... . The inverse relationship between PASP and Tiffno index (p=0.03) and a positive correlation between forced ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... and parathyroidectomy (p<0.05). BP reduction not requiring antihypertensive drugs dose adjustment was found in patients ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... more often in women than these in men after 1, 3 and 6 months, respectively , (p>0.05). Mean age ..."
 
Vol 16, No 6 (2020) Role of Speckle Tracking in the Evaluation of Left Ventricular Remodeling After Streptokinase Infusion in Patients with Acute Anterior Myocardial Infarction Abstract  PDF (Eng)  similar documents
Sh. I. Farag, Kh. E. El-Rabbat, M. A. El-Awadi, A. M. Sabry
"... , p<0.001). GLS cutoff value of >-13.5 was shown to have the best diagnostic accuracy (sensitivity =60 ..."
 
Vol 7, No 3 (2011) POTASSIUM INTAKE, STROKE, AND CARDIOVASCULAR DISEASE: A META-ANALYSIS OF PROSPECTIVE STUDIES  similar documents
L. D'Elia, G. Barba, F. P. Cappuccio, P. Strazzullo
 
Vol 2, No 2 (2006) COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova
"... in the 1st group increased by 14% before glucose load, and by 25% (p<0,05) 2 hours after peroral glucose ..."
 
Vol 6, No 3 (2010) HOMOEOPATHY IN THE ERA OF EVIDENCE BASED MEDICINE Abstract  similar documents
N. P. Kutishenko
 
Vol 8, No 1 (2012) RANOLAZINE IN ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
 
Vol 8, No 3 (2012) CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS Abstract  similar documents
V. P. Volkov
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
 
Vol 3, No 5 (2007) THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
D. P. Sementsov
 
Vol 1, No 2 (2005) ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE Abstract  similar documents
P. P. Tikhonov, L. A. Sokolova
 
Vol 15, No 5 (2019) Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis Abstract  similar documents
D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich
"... women and 70 men; in women, AH was recorded more often than in men: 88.9% and 66.0%, respectively, p<0 ..."
 
Vol 10, No 2 (2014) PUBLIC HEALTH: FOCUS ON THE PREVENTION Abstract  similar documents
P. Puska, N. V. Dolgushina
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... Translation articles:  G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G ..."
 
Vol 8, No 2 (2012) CONFLICT OF INTEREST POLICIES AND DISCLOSURE REQUIREMENTS AMONG EUROPEAN SOCIETY OF CARDIOLOGY NATIONAL CARDIOVASCULAR JOURNALS  similar documents
F. Alfonso, A. Timmis, F. J. Pinto, G. Ambrosio, H. Ector, P. Kulakowski, P. Vardas
 
Vol 14, No 1 (2018) OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY Abstract  similar documents
N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich
"... significantly more often than in the LIS-3 registry (49.4% vs 39.4%, respectively, p<0.05), as well as calcium ..."
 
Vol 14, No 5 (2018) Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” Abstract  similar documents
N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich
"... on the endpoint were age (relative risk [RR] 1,05; 95% confidence interval [CI] 1.01-1.09, p=0.016), the presence ..."
 
Vol 16, No 5 (2020) Untapped Possibilities of Antiischemic Therapy after Acute Myocardial Infarction: Data from the PROFILE-IM Register Abstract  similar documents
E. P. Kalaydzhyan, S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, O. M. Drapkina
"... in the rest of the group (p<0.001). Conclusion. In real clinical practice, only a small part of patients ..."
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
 
Vol 3, No 1 (2007) GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING) Abstract  similar documents
K. Fox, M. A. A. Garcia, D. Ardissimo, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. de Backer, P. Hjenmdahl, J. Lopez-Sendon, J. Marco, J. Morais, J. Pepper, U. Sechtem, M. Simoons, K. Thygesen
 
Vol 5, No 6 (2009) PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES Abstract  PDF (Eng)  similar documents
O. V. Reshetko, N. V. Furman, R. M. Magdeev, Ya. P. Ya.P. Dovgalevskiy
 
Vol 13, No 3 (2017) EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY Abstract  similar documents
V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya
"... injection of epinephrine in both theLV (3.95±0.64-vs 6.83±0.30 vol% in the control group; p<0.05) and RV (4 ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... factors and associated with a 3-fold increased risk of cardiovascular events (RR 3.27; 95% CI 2.49-4.30; p ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... elective cardioversion was 21±2 and 30.5±4.5 days for dabigatran and warfarin groups, respectively (p<0 ..."
 
Vol 2, No 3 (2006) EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE Abstract  similar documents
M. P. Rubanova, V. R. Veber, I. A. Suhenko, P. M. Gubskaya
 
Vol 12, No 5 (2016) Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
 
Vol 12, No 5 (2016) News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
 
Vol 5, No 3 (2009) ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
N. M. Nikitina, A. P. Rebrov
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... hypertension (r=0,21, p<0,05), end-diastolic dimension of right ventricle (r=0,24, p<0,05) and left ventricle ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... .  Results. Over three year follow-up actively managed patients demonstrated significant (p<0.05) decrease ..."
 
Vol 13, No 4 (2017) CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS Abstract  similar documents
N. A. Karoli, A. P. Rebrov
"... were associated with smoking status (r=0.61, p<0.01), severity of bronchial obstruction (r=-0.49, p<0 ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... .0 vs 107.3±42.1 points, p=0.9). Conclusion. Individualized choice of anticoagulant in patients with AF ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
 
Vol 6, No 3 (2010) THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS Abstract  similar documents
N. A. Kosheleva, A. P. Rebrov
 
Vol 7, No 4 (2011) THE STICH TRIAL — THE IMPORTANCE OF DRUGS IN PATIENTS WITH CORONARY ARTERY DISEASE WAS HIGHER THAN EXPECTED Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
 
Vol 7, No 5 (2011) ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS Abstract  similar documents
G. P. Arutyunov, L. G. Oganezova
"... was higher than this in enalaprilat group (96.7 vs 73.3%; p<0.001), for the first hour systolic BP (SBP ..."
 
Vol 6, No 5 (2010) FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. O. Shevchenko, O. P. Shevchenko
 
Vol 10, No 2 (2014) RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Abstract  similar documents
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson
 
Vol 16, No 2 (2020) Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation Abstract  similar documents
Yu. P. Skirdenko, N. A. Nikolaev
"... anticoagulants (DOACs) (χ2=1.44; p<0.49, Pearson) and significantly more in individuals taking warfarin ..."
 
Vol 10, No 5 (2014) NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 11, No 5 (2015) News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... in the blood plasma 5.42 (5.26–5.76) vs 4.88 (4.86–4.94) hours, respectively; p<0.001. Original enalapril ..."
 
Vol 3, No 5 (2007) LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE Abstract  similar documents
N. P. Kutishenko, S. J. Martsevich
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
 
Vol 16, No 4 (2020) From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases Abstract  similar documents
P. A. Lebedev, A. A. Garanin
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 4, No 2 (2008) ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? Abstract  similar documents
A. L. Komarov, E. P. Panchenko
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
 
Vol 4, No 5 (2008) CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 4, No 5 (2008) CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION Abstract  similar documents
D. A. Poddubnyy, A. P. Rebrov
"... .0%(3,0; 11,0), respectively (p<0,05). 10-year risk of fatal cardiovascular event in studied group ..."
 
Vol 15, No 3 (2019) Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage Abstract  similar documents
V. V. Rameev, R. P. Myasnikov, P. P. Vinogradov, L. V. Kozlovskaya, S. V. Moiseev, E. I. Fomicheva, S. A. Beregovskaya, E. A. Mershina, S. A. Kostina, L. A. Strizhakov, A. S. Rameeva, P. P. Tao, O. M. Drapkina
 
Vol 8, No 1 (2012) URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL  similar documents
S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker
 
Vol 12, No 6 (2016) EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND Abstract  similar documents
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov
"... was found during amlodipine therapy in both groups: from 34.5±8.7 to 84.8±14.8 (p=0.006) in the Group 1 ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p<0.001) and from 6.0±0.7 to 4.1±0.7 mmol/l (p<0 ..."
 
Vol 9, No 3 (2013) EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA) Abstract  similar documents
, , , , , , , , , , ,
 
Vol 10, No 2 (2014) IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, M. L. Gynzburg, L. Yu. Drozdova, A. D. Deev, V. P. Smirnov
"... in this group of patients was significantly higher than this in the whole group of patients (15.2%; p=0 ..."
 
Vol 1, No 2 (2005) ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS Abstract  similar documents
G. V. Andreeva, S. Y. Martsevich, V. M. Gorbunov, O. A. Melnikov, V. P. Voronina, I. P. Zhigareva
 
Vol 8, No 2 (2012) 1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW Abstract  similar documents
R. R. Mamatkazina, I. P. Kolos, S. E. Serdyuk, E. P. Mazygula, A. V. Sveshnikov
 
Vol 16, No 5 (2020) Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation Abstract  similar documents
E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko
 
Vol 16, No 5 (2020) The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis Abstract  similar documents
S. P. Abdullaev, K. B. Mirzaev, P. O. Bochkov, I. N. Sychev, D. A. Sychev
"... [CI] 0.629-0.851; p<0.001). The heterogeneity test did not reveal any reliable differences between ..."
 
Vol 17, No 1 (2021) Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong Abstract  similar documents
A. N. Petrenko, P. A. Vasiliev, S. Yu. Martsevich, N. P. Kutishenko, O. I. Zvonareva
 
Vol 4, No 4 (2008) INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova
 
Vol 12, No 2 (2016) SYSTEMATIC REVIEW AND META-ANALYSIS: PITFALLS OF METHODS Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
 
Vol 12, No 6 (2016) THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev
"... .0 (2.0, 5.0) to 1.2 (0.7, 2.0); p<0.01] and compared to the placebo group [2.0 (1.0, 3.0); p=0 ..."
 
Vol 12, No 6 (2016) BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION Abstract  similar documents
Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova
"... }3.67 points vs 24.6Ѓ}4.3 and 20.1Ѓ}5.7 points in group 2, and group of healthy, respectively; p<0 ..."
 
Vol 13, No 1 (2017) VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE Abstract  similar documents
V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova
 
Vol 5, No 5 (2009) INFLUENCE OF THE COMBINED ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
E. M. Idrisova, T. P. Kalashnikova, I. Yu. Efimova
 
Vol 7, No 2 (2011) EVALUATION OF CARDIOVASCULAR RISK FACTORS PREVALENCE AND EFFICACY OF THEIR CORRECTION IN PHYSICIANS. ESTIMATION OF PHYSICIANS’ EXPERTISE IN UP-TO-DATE CLINICAL GUIDELINES. RESULTS OF THE “PHYSICIAN’S HEALTH AND EDUCATION” STUDY Abstract  similar documents
L. Y. Drozdova, S Y. Martsevich, V. P. Voronina
 
Vol 7, No 2 (2011) WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina
 
Vol 6, No 1 (2010) HEALTH AND EDUCATION OF A PHYSICIAN: TWO PARTS OF THE SUCCESS Abstract  similar documents
S. Yu. Martsevich, L. Yu. Drozdova, V. P. Voronina
 
Vol 13, No 2 (2017) ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE Abstract  similar documents
S. N. Tolstov, I. A. Salov, A. P. Rebrov
"... group (p=0.7). The relationships between EDVD parameters and levels of ADMA (r=-0.31, p=0.029) and NOx ..."
 
Vol 13, No 2 (2017) FACTORS INFLUENCING THE FORMATION OF BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION Abstract  similar documents
Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova
 
Vol 13, No 2 (2017) ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES Abstract  similar documents
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko
 
Vol 13, No 4 (2017) THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES Abstract  similar documents
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
 
Vol 7, No 3 (2011) THE NEWS FROM RECENT CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY (NEW ORLEANS, APRIL 2-5, 2011)  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Y. Drozdova
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
 
Vol 9, No 3 (2013) HOW TO STAND UP PLAGIARISM IN THE SCIENTIFIC MEDICAL PUBLICATIONS? Abstract  similar documents
R. G. Oganov, N. P. Kutishenko, D. A. Anitchkov
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
 
Vol 10, No 1 (2014) HOW TO INCREASE ACCESSIBILITY OF BIOMEDICAL INFORMATION? EDITORS’ NETWORK INITIATIVE OF THE NATIONAL SOCIETY CARDIOVASCULAR JOURNALS OF THE EUROPEAN SOCIETY OF CARDIOLOGY Abstract  similar documents
I. P. Kolos, D. A. Anichkov, R. G. Oganov
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
 
1 - 100 of 321 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)